Novartis Healthcare Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 25-06-2024
- Paid Up Capital ₹ 6.00 Cr
as on 25-06-2024
- Company Age 27 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.00 Cr
as on 25-06-2024
- Revenue 17.19%
(FY 2022)
- Profit 36.46%
(FY 2022)
- Ebitda 16.60%
(FY 2022)
- Net Worth 36.49%
(FY 2022)
- Total Assets 15.97%
(FY 2022)
About Novartis Healthcare
The Corporate was formerly known as Novartis Consumer Health (I) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 6.00 Cr.
The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Naveen Gullapalli, Pushpa Adhikary, and Amitabh Dube serve as directors at the Company.
- CIN/LLPIN
U15202MH1997PTC111257
- Company No.
111257
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 1997
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Novartis Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amitabh Dube  | Managing Director | 01-Sep-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naveen Gullapalli | Whole-Time Director | 13-Jun-2014 | Current |
Pushpa Adhikary  | Director | 07-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Novartis Healthcare.
Novartis Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.19% increase. The company also saw a substantial improvement in profitability, with a 36.46% increase in profit. The company's net worth Soared by an impressive increase of 36.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novartis Healthcare?
In 2022, Novartis Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 21 Sep 1998 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Novartis Healthcare?
Novartis Healthcare has a workforce of 8369 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novartis Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novartis Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
